Holen Sie sich die Stockscreener-App
18.12
1.09%
-0.20
Handel nachbörslich:
18.12
Schlusskurs vom Vortag:
$18.32
Offen:
$18.14
24-Stunden-Volumen:
1.37M
Relative Volume:
0.58
Marktkapitalisierung:
$5.15B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$24.82M
KGV:
226.50
EPS:
0.08
Netto-Cashflow:
$105.89M
1W Leistung:
-2.11%
1M Leistung:
+2.08%
6M Leistung:
+52.08%
1J Leistung:
+29.89%
1-Tages-Spanne:
$17.91
$18.26
1-Wochen-Bereich:
$17.85
$18.99
52-Wochen-Spanne:
$9.53
$19.85
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Vergleichen Sie SHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
18.12 | 5.20B | 1.11B | 24.82M | 105.89M | 0.08 |
|
TMO
Thermo Fisher Scientific Inc
|
578.61 | 222.48B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
218.89 | 155.25B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
670.46 | 54.04B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
230.15 | 40.13B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.85 | 37.78B | 6.95B | 1.30B | 1.15B | 4.5696 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Sotera Health Company's (NASDAQ:SHC) institutional investors lost 3.1% last week but have benefitted from longer-term gains - simplywall.st
Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews
Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and a Promising 6.56% Upside - DirectorsTalk Interviews
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside - DirectorsTalk Interviews
3 Unpopular Stocks with Open Questions - Finviz
Dip Buying: Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 News Drivers & Fast Entry High Yield Stock Tips - Bộ Nội Vụ
Sterilization Services MarketGlobal Forecast 2025-2032: - GlobeNewswire
Sotera Health to Seek M&A Opportunities - marketscreener.com
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sotera Health to Showcase Continued Revenue Growth and - GlobeNewswire
Sotera Health Shows Market Leadership With Jump To 83 RS Rating - MSN
Sotera Health (NASDAQ:SHC) Rating Increased to Moderate Buy at Royal Bank Of Canada - MarketBeat
SHC: Sotera Health Receives 'Outperform' Rating from RBC Capital - GuruFocus
Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand - Investing.com Nigeria
Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand By Investing.com - Investing.com South Africa
Piper Sandler Upgrades Sotera Health (SHC) with a New Target Pri - GuruFocus
Sotera Health (SHC) Receives Positive Outlook with Strong Growth Potential - GuruFocus
Is Sotera Health Company (NASDAQ:SHC) Potentially Undervalued? - simplywall.st
RBC Capital initiates Sotera Health stock with Outperform rating By Investing.com - Investing.com Canada
Will Sotera Health Company stock keep outperforming rivalsJuly 2025 Momentum & Capital Efficient Trading Techniques - Улправда
Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - AOL.com
Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - The Motley Fool
Form 424B7Prospectus [Rule 424(b)(7)] - ADVFN
Form 8-KCurrent report - ADVFN
RBC Capital initiates Sotera Health stock with Outperform rating - Investing.com
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Sotera Health (NASDAQ:SHC) Sets New 12-Month HighTime to Buy? - MarketBeat
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 31% Undervalued - Yahoo Finance
Sotera Health (NASDAQ:SHC) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Sotera Health Co stock hits 52-week high at 17.83 USD - Investing.com
Sotera Health (NASDAQ:SHC) Sets New 1-Year High – Still a Buy? - Defense World
Sotera Health (NASDAQ:SHC) Hits New 1-Year HighShould You Buy? - MarketBeat
Sotera Health Co stock hits 52-week high at $17.79 By Investing.com - Investing.com Nigeria
Sotera Health Co stock hits 52-week high at $17.79 - Investing.com
Sotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sotera Health Company (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Q3 Research Tools & Consumables Earnings: Sotera Health Company (NASDAQ:SHC) Earns Top Marks - Yahoo Finance
Sotera Health (NASDAQ:SHC) versus Surgery Partners (NASDAQ:SGRY) Financial Review - Defense World
1 Small-Cap Stock to Target This Week and 2 We Ignore - Finviz
Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 Opening Moves & Safe Capital Investment Plans - Улправда
Stock Report: Will Sotera Health Company stock benefit from green energy trendsQuarterly Investment Review & AI Based Buy and Sell Signals - Улправда
Can Sotera Health Company stock hit record highs againEarnings Overview Summary & High Accuracy Trade Signal Alerts - bolumsonucanavari.com
With 48% ownership, Sotera Health Company (NASDAQ:SHC) has piqued the interest of institutional investors - Yahoo Finance
Sotera Health Looks Undervalued, Analyst SaysSotera Health (NASDAQ:SHC) - Benzinga
Sotera Health stock rating initiated at Outperform by William Blair - Investing.com Nigeria
Sotera Health (SHC) Coverage Initiated with 'Outperform' Rating by William Blair | SHC Stock News - GuruFocus
Sotera Health, Warburg Pincus, and GTCR in $470 Million Secondary Stock Offering - Cleary Gottlieb
Sotera Health (SHC): Reassessing Valuation After Major Secondary Share Sale and Earnings Beat - simplywall.st
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):